Canakinumab Subcutaneous and Dextromethorphan, diphenhydramine, and phenylephrine
Determining the interaction of Canakinumab Subcutaneous and Dextromethorphan, diphenhydramine, and phenylephrine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dextromethorphan / diphenhydramine / phenylephrine
Brand name: Dytan-DM, Triaminic Day Time Night Time Cold & Cough, Duratuss AC 12, D-Tann DM
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dextromethorphan, doxylamine, and pseudoephedrine
- Canakinumab Subcutaneous-Dextromethorphan, guaifenesin, and phenylephrine
- Canakinumab Subcutaneous-Dextromethorphan, guaifenesin, and pseudoephedrine
- Canakinumab Subcutaneous-Dextromethorphan, Pheniramine, and Phenylephrine Powder Packets
- Canakinumab Subcutaneous-Dextromethorphan, phenylephrine, and pyrilamine
- Canakinumab Subcutaneous-Dextrose
- Dextromethorphan, diphenhydramine, and phenylephrine-Canasa
- Dextromethorphan, diphenhydramine, and phenylephrine-Canasa Pac rectal
- Dextromethorphan, diphenhydramine, and phenylephrine-Canasa rectal
- Dextromethorphan, diphenhydramine, and phenylephrine-Cancidas
- Dextromethorphan, diphenhydramine, and phenylephrine-Candesartan
- Dextromethorphan, diphenhydramine, and phenylephrine-Candesartan and Hydrochlorothiazide